Results3 Feb 2021 16:48
Thought i would start a new thread. So actually looking at the results, for 2020, they looked ok. Drop in debt, increase in equity, increase in revenue and profit? So the drop is mainly due to future forecasts for 2022 and discounting that? The zurich Financial Crisis Observatory actually included GSK in their last report (January), and even said this is over sold in negative bubble territory. So will be interesting to see what happens. I think it has been oversold, but please tell me otherwise.